Christopher Hover
Physician Assistant · Wilmington, DENPI 1275105892
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,568 of the $5,089 with a category attached, or 70.1%. 32 manufacturers reported payments, led by MML US, Inc. at 33.0% of the total. Reporting peaked in 2021 at $1,650 and has fallen 59.6% since, to $667 in 2025. Among physician assistant clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $25.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MML US, Inc.$2K
- Collegium Pharmaceutical, Inc.$613
- Scilex Pharmaceuticals Inc.$548
- Valinor Pharma, LLC$547
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$351
- Boston Scientific$277
- plus $1K from 26 others
What the payments were for
- Travel & lodging$1,52130%
- Food & beverage$3,56870%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MML US, Inc. | 11 | $1,679 |
| Collegium Pharmaceutical, Inc. | 45 | $613 |
| Scilex Pharmaceuticals Inc. | 28 | $548 |
| Valinor Pharma, LLC | 37 | $547 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $351 |
| Boston Scientific | 8 | $277 |
| Tersera Therapeutics LLC | 8 | $254 |
| Medtronic | 2 | $136 |
| Pfizer | 5 | $80 |
| Impel Pharmaceuticals LLC | 4 | $78 |
| Vertos Medical, Inc. | 2 | $69 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| IBSA Pharma Inc. | 2 | $48 |
| Fidia Pharma USA Inc. | 1 | $40 |
| Ossur Americas, Inc. | 1 | $31 |
| Novo Nordisk | 1 | $20 |
| Si-bone, Inc. | 1 | $19 |
| Averitas Pharma Inc. | 1 | $19 |
| SPR Therapeutics, Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Appliedvr Inc | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Spinal Simplicity, LLC | 1 | $15 |
| International Rehabilitative Sciences, Inc | 1 | $15 |
| GRT US Holding, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ReActiv8$1,533
- INTELLIS ADAPTIVESTIM$113
How this compares
$5,089 in reported general payments places this provider in the 95th percentile of 527 physician assistant providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 114 | $92,700 |
| Xtampza ErOxycodone Myristate | 90 | $59,566 |
| MovantikNaloxegol Oxalate | 96 | $38,746 |
| OxycontinOxycodone Hcl | 45 | $28,478 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 853 | $24,666 |
| NeurontinGabapentin | 12 | $20,496 |
| Nucynta ErTapentadol Hcl | 18 | $17,712 |
| Oxycodone Hcl | 906 | $16,108 |
| NucyntaTapentadol Hcl | 13 | $15,554 |
| Buprenorphine | 46 | $11,336 |
| ZtlidoLidocaine | 14 | $11,144 |
| Morphine Sulfate ErMorphine Sulfate | 315 | $8,242 |
| Tramadol Hcl ErTramadol Hcl | 109 | $7,927 |
| Lidocaine | 63 | $6,874 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 257 | $5,844 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er, Nucynta | $613 | $185,532235 claims |
| Redhill Biopharma Inc.Movantik | $16 | $38,74696 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $548 | $11,14414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 527 physician assistant providers in Delaware.
Other physician assistant in Wilmington
- Jason SaulWilmington$9K
- Brooke EnderleWilmington$7K
- Matthew StumpWilmington$5K
- Julie SimsWilmington$5K
- Joan TaddeiWilmington$4K
- Gabriel PelaezWilmington$4K
- Caitlin McCarryWilmington$4K
- Samantha DelfeldWilmington$4K
- Shannon MohollenWilmington$4K
- Victoria SandlerWilmington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.